Results 91 to 100 of about 32,805 (191)

Plasminogen Activator Inhibitor‐1 is Internalized by Endothelial Cells via A Pinocytosis‐Like Mechanism and Evades Degradation

The FASEB Journal, Volume 40, Issue 10, 31 May 2026.
Plasminogen activator inhibitor 1 (PAI1) is a secreted protein that also regulates intracellular processes, such as inhibition of endothelial nitric oxide synthase (eNOS). Interaction between Plasminogen Activators (PA) and PAI1 results in a covalent linkage.
Molly McAdow, Gjina Ahmetaj, Rachel Hauschel, Anne Eichmann, William Sessa   +4 more
wiley   +1 more source

Safety and efficacy of tirofiban after intravenous thrombolysis with urokinase in patients with acute ischemic stroke

Frontiers in Neurology
IntroductionTirofiban combined with alteplase thrombolysis or endovascular therapy has been proven to improve the prognosis of patients with acute ischemic stroke (AIS).
Dian Qu, Huanhuan Liu, Zhongming Wei, Yao Cheng, Yutong Fei, Jinghan Xu, Xiuyu Lv, Wendi Li   +7 more
doaj   +1 more source

Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge

Folia Histochemica et Cytobiologica, 2010
Urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) are involved in tiisue remodeling and repairprocesses associated with acute and chronic inflammation. The aim of the study was to evaluate the effect of allergen challengeon concentration of
Krzysztof Kowal,, Marcin Moniuszko, Sebastian Zukowski, Anna Bodzenta-Lukaszyk   +3 more
doaj  

The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Koc BL, Tanacan A, Haliloglu E, Yilmaz HE, Ersak DT, Aktas BA, Kara O, Sahin D.   +7 more
europepmc   +1 more source

Thrombolysis for pulmonary embolism: A network meta-analysis. [PDF]

J Intensive Care Soc
Ross A, Glaister P, Robinson N, Crossingham I.   +3 more
europepmc   +1 more source

Efficacy and safety of urokinase in the treatment of loculated pleural effusions caused by various etiologies: a systematic review and meta-analysis. [PDF]

J Thorac Dis
Jiang T, Chen W, Liang G, Peng Z, Tang J, Tang Q, He L.   +6 more
europepmc   +1 more source

Efficacy and safety of tenecteplase versus urokinase in the treatment of acute ischemic stroke. [PDF]

Medicine (Baltimore)
Li D, Huang S, Wang X, Hong Z, Qiu X.
europepmc   +1 more source

Intracoronary urokinase infusion during prolonged perfusion balloon inflation for massive thrombus in acute myocardial infarction: case series. [PDF]

J Cardiol Cases
Ujiro S, Yamamoto H, Kinutani H, Takaya T.   +3 more
europepmc   +1 more source

Adjunctive therapeutic strategy for in-stent thrombosis: <i>in vitro</i> pharmacodynamic evaluation of COX-1 inhibitor 3d combined with catheter-directed thrombolysis. [PDF]

RSC Adv
Ma B, Liang Z, Fu L, Ma Y, Sun Q, Lv X.
europepmc   +1 more source

Adaption of the plasmin generation assay to enhance sensitivity to plasminogen activator inhibitor-1 and establishment of sex-specific reference values in human plasma. [PDF]

Res Pract Thromb Haemost
De Simone I, Pocknell K, Tufaha S, Konings J, Roest M, Wolberg AS, Whyte CS, Mutch NJ, de Laat B, Huskens D.   +9 more
europepmc   +1 more source